BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 37190216)

  • 21. Current Microsatellite Instability Testing in Management of Colorectal Cancer.
    Sun BL
    Clin Colorectal Cancer; 2021 Mar; 20(1):e12-e20. PubMed ID: 32888812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice.
    Nakayama I; Shinozaki E; Kawachi H; Sasaki T; Yunokawa M; Tomomatsu J; Yuasa T; Kitazono S; Kobayashi K; Hayakawa K; Ueki A; Takahashi S; Yamaguchi K
    Cancer Med; 2023 Apr; 12(7):7932-7940. PubMed ID: 36573309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of microsatellite stability status in colorectal cancer.
    Gupta R; Sinha S; Paul RN
    Curr Probl Cancer; 2018 Nov; 42(6):548-559. PubMed ID: 30119911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers.
    Eso Y; Shimizu T; Takeda H; Takai A; Marusawa H
    J Gastroenterol; 2020 Jan; 55(1):15-26. PubMed ID: 31494725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockade.
    Wang T; Lee LH; Vyas M; Zhang L; Ganesh K; Firat C; Segal NH; Desai A; Hechtman JF; Ntiamoah P; Weiser MR; Markowitz AJ; Vakiani E; Klimstra DS; Stadler ZK; Shia J
    Mod Pathol; 2019 Oct; 32(10):1551-1562. PubMed ID: 31175329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term benefit of immunotherapy in a patient with squamous lung cancer exhibiting mismatch repair deficient/high microsatellite instability/high tumor mutational burden: A case report and literature review.
    Li N; Wan Z; Lu D; Chen R; Ye X
    Front Immunol; 2022; 13():1088683. PubMed ID: 36703977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A TGFβ-Dependent Stromal Subset Underlies Immune Checkpoint Inhibitor Efficacy in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer.
    Endo E; Okayama H; Saito K; Nakajima S; Yamada L; Ujiie D; Kase K; Fujita S; Endo H; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
    Mol Cancer Res; 2020 Sep; 18(9):1402-1413. PubMed ID: 32493700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer.
    Horimoto Y; Thinzar Hlaing M; Saeki H; Kitano S; Nakai K; Sasaki R; Kurisaki-Arakawa A; Arakawa A; Otsuji N; Matsuoka S; Tokuda E; Arai M; Saito M
    Cancer Sci; 2020 Jul; 111(7):2647-2654. PubMed ID: 32449246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite instability and oncological outcomes in Thai patients with endometrial cancer.
    Atjimakul T; Wattanapaisal P; Suwiwat S; Wanichsuwan W; Hanprasertpong J
    J Obstet Gynaecol; 2022 Oct; 42(7):3117-3123. PubMed ID: 35930016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
    T Danley K; Schmitz K; Ghai R; Sclamberg JS; Buckingham LE; Burgess K; Kuzel TM; Usha L
    Oncologist; 2021 Oct; 26(10):811-817. PubMed ID: 34018286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency.
    Cohen R; Colle R; Pudlarz T; Heran M; Duval A; Svrcek M; André T
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33800202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls.
    Adeleke S; Haslam A; Choy A; Diaz-Cano S; Galante JR; Mikropoulos C; Boussios S
    Per Med; 2022 Jul; 19(4):277-286. PubMed ID: 35708161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in histological features and PD-L1 expression between sporadic microsatellite instability and Lynch-syndrome-associated disease in Japanese patients with colorectal cancer.
    Yamada R; Yamaguchi T; Iijima T; Wakaume R; Takao M; Koizumi K; Hishima T; Horiguchi SI
    Int J Clin Oncol; 2018 Jun; 23(3):504-513. PubMed ID: 29327160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors.
    Akagi K; Oki E; Taniguchi H; Nakatani K; Aoki D; Kuwata T; Yoshino T
    Cancer Sci; 2021 Mar; 112(3):1105-1113. PubMed ID: 33403729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors.
    Svrcek M; Lascols O; Cohen R; Collura A; Jonchère V; Fléjou JF; Buhard O; Duval A
    Bull Cancer; 2019 Feb; 106(2):119-128. PubMed ID: 30713006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches.
    Tan E; Sahin IH
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):735-742. PubMed ID: 33539189
    [No Abstract]   [Full Text] [Related]  

  • 37. The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers.
    Han S; Chok AY; Peh DYY; Ho JZ; Tan EKW; Koo SL; Tan IB; Ong JC
    Front Genet; 2022; 13():933475. PubMed ID: 36531239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of microsatellite instability in colorectal cancer.
    Kloor M; Staffa L; Ahadova A; von Knebel Doeberitz M
    Langenbecks Arch Surg; 2014 Jan; 399(1):23-31. PubMed ID: 24048684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status and perspectives of immune checkpoint inhibitors for colorectal cancer.
    Hirano H; Takashima A; Hamaguchi T; Shida D; Kanemitsu Y;
    Jpn J Clin Oncol; 2021 Jan; 51(1):10-19. PubMed ID: 33205813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mismatch repair deficiency: The what, how and why it is important.
    Olave MC; Graham RP
    Genes Chromosomes Cancer; 2022 Jun; 61(6):314-321. PubMed ID: 34837268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.